High-density lipoprotein and the acute phase response - PubMed (original) (raw)
Review
High-density lipoprotein and the acute phase response
Anisa Jahangiri. Curr Opin Endocrinol Diabetes Obes. 2010 Apr.
Abstract
Purpose of review: Inflammation and the concomitant acute phase response induce marked changes in the lipoprotein profile, particularly the high-density lipoprotein (HDL) fraction. The present review describes the transfer proteins and lipases that remodel HDL and regulate its plasma levels, discusses the changes occurring in their activities during inflammation, and the influence of this altered remodeling on HDL function. The review will also discuss the contribution of the ATP-binding-membrane-cassette transporters to the protective actions of HDL.
Recent findings: Studies using different models showed that remodeling of acute phase HDL in vitro generates pre-beta migrating particles capable of cholesterol efflux. Induction of the acute phase response in humans resulted in a reduction of HDL phospholipids without a change in HDL-cholesterol. However, the capacity of HDL to promote cholesterol efflux ex vivo was impaired. Studies with ATP-binding-membrane-cassette transporter A1 and ATP-binding-membrane-cassette transporter G1 knockout mice demonstrated anti-inflammatory roles for these transporters by virtue of reducing cell-membrane-free cholesterol and lipid raft content, thus attenuating proinflammatory signaling pathways.
Summary: It is well known that HDL has anti-inflammatory properties that are diminished during inflammation. Acute phase HDL contains serum amyloid A that can be liberated during remodeling by cholesteryl ester transfer protein and secretory phospholipase A2, or other inflammatory factors. The ability of serum amyloid A and apolipoprotein A-I to promote cholesterol efflux may confer protective effects during the acute phase response.
Similar articles
- HDL remodeling during the acute phase response.
Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, Webb NR, van der Westhuyzen DR, de Beer FC. Jahangiri A, et al. Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):261-7. doi: 10.1161/ATVBAHA.108.178681. Epub 2008 Nov 13. Arterioscler Thromb Vasc Biol. 2009. PMID: 19008529 Free PMC article. - Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
Favari E, Lee M, Calabresi L, Franceschini G, Zimetti F, Bernini F, Kovanen PT. Favari E, et al. J Biol Chem. 2004 Mar 12;279(11):9930-6. doi: 10.1074/jbc.M312476200. Epub 2003 Dec 29. J Biol Chem. 2004. PMID: 14701812 - HDL cholesterol transport during inflammation.
van der Westhuyzen DR, de Beer FC, Webb NR. van der Westhuyzen DR, et al. Curr Opin Lipidol. 2007 Apr;18(2):147-51. doi: 10.1097/MOL.0b013e328051b4fe. Curr Opin Lipidol. 2007. PMID: 17353662 Review. - Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial.
Song G, Lin Q, Zhao H, Liu M, Ye F, Sun Y, Yu Y, Guo S, Jiao P, Wu Y, Ding G, Xiao Q, Qin S. Song G, et al. J Clin Endocrinol Metab. 2015 Jul;100(7):2724-33. doi: 10.1210/jc.2015-1321. Epub 2015 May 15. J Clin Endocrinol Metab. 2015. PMID: 25978109 Clinical Trial.
Cited by
- Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites.
Chan SY, Probert F, Radford-Smith DE, Hebert JC, Claridge TDW, Anthony DC, Burnet PWJ. Chan SY, et al. Sci Rep. 2020 Oct 8;10(1):16857. doi: 10.1038/s41598-020-74008-w. Sci Rep. 2020. PMID: 33033375 Free PMC article. - Synergy between serum amyloid A and secretory phospholipase A2.
Jayaraman S, Fändrich M, Gursky O. Jayaraman S, et al. Elife. 2019 May 21;8:e46630. doi: 10.7554/eLife.46630. Elife. 2019. PMID: 31111824 Free PMC article. - Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.
Jayaraman S, Haupt C, Gursky O. Jayaraman S, et al. J Lipid Res. 2015 Aug;56(8):1531-42. doi: 10.1194/jlr.M059162. Epub 2015 May 28. J Lipid Res. 2015. PMID: 26022803 Free PMC article. - Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis.
Berg AR, Petrole RF, Li H, Sorokin AV, Gonzalez-Cantero A, Playford MP, Mehta NN, Teague HL. Berg AR, et al. Front Cardiovasc Med. 2023 Feb 20;10:1041457. doi: 10.3389/fcvm.2023.1041457. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36891247 Free PMC article. - High density lipoprotein: it's not just about lipid transport anymore.
Gordon SM, Hofmann S, Askew DS, Davidson WS. Gordon SM, et al. Trends Endocrinol Metab. 2011 Jan;22(1):9-15. doi: 10.1016/j.tem.2010.10.001. Epub 2010 Nov 8. Trends Endocrinol Metab. 2011. PMID: 21067941 Free PMC article. Review.
References
- Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357:1301–1310. - PubMed
- Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res. 2004;95:764–772. - PubMed
- Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221–1232. - PubMed
- Gelissen IC, Harris M, Rye KA, et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol. 2006;26:534–540. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials